All Curated Mutation Sites in IV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in IV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
HA1
  
HA2
  
M1
  
M2
  
NA
  
NP
  
NS1
  
NS2
  
PA
  
PB1
  
PB2
  

Keyword: Influenza A-29145498
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 29145498 P200S
HA1
HA
Influenza A
Influenza B
G
R
L
View
2 29145498 S202T
HA1
HA
Influenza A
Influenza B
G
R
L
View
3 29145498 I321V
NA
NA
Influenza A
Influenza B
G
R
L
View
4 29145498 I34V
NA
NA
Influenza A
Influenza B
G
R
L
View
5 29145498 N200S
NA
NA
Influenza A
Influenza B
G
R
L
View
6 29145498 N248D
NA
NA
Influenza A
Influenza B
G
R
L
View
7 29145498 N369K
NA
NA
Influenza A
Influenza B
G
R
L
View
8 29145498 I233T
HA
HA
Influenza A
Influenza B
G
R
L
View
9 29145498 I338V
HA
HA
Influenza A
Influenza B
G
R
L
View
10 29145498 K180Q
HA
HA
Influenza A
Influenza B
G
R
L
View
11 29145498 P100S
HA
HA
Influenza A
Influenza B
G
R
L
View
12 29145498 S101N
HA
HA
Influenza A
Influenza B
G
R
L
View
13 29145498 S179N
HA
HA
Influenza A
Influenza B
G
R
L
View
14 29145498 S207R
HA
HA
Influenza A
Influenza B
G
R
L
View
15 29145498 S220T
HA
HA
Influenza A
Influenza B
G
R
L
View
16 29145498 T214A
HA
HA
Influenza A
Influenza B
G
R
L
View
17 29145498 T472N
HA
HA
Influenza A
Influenza B
G
R
L
View
18 29145498 K432E
NA
NA
Influenza A
Influenza B
G
R
L
View
19 29145498 V241I
NA
NA
Influenza A
Influenza B
G
R
L
View
Contents
Description

The table shows all curated mutation sites of IV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.